| scholarly article | Q13442814 |
| P2093 | author name string | Jing Zhao | |
| Lei Wang | |||
| Rui Zhang | |||
| Xiao Zhang | |||
| Bo Yan | |||
| Xiang Zhang | |||
| An-Gang Yang | |||
| Lin-Tao Jia | |||
| Shu-Li Cheng | |||
| Ka Bian | |||
| Noor Gammoh | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| MicroRNA expression, survival, and response to interferon in liver cancer | Q24647241 | ||
| Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| Anoikis molecular pathways and its role in cancer progression | Q26852158 | ||
| Mammalian microRNAs predominantly act to decrease target mRNA levels | Q27860535 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B | Q28216726 | ||
| MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin | Q28263940 | ||
| MYC stimulates EZH2 expression by repression of its negative regulator miR-26a | Q28291303 | ||
| A perspective on cancer cell metastasis | Q28307891 | ||
| Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB | Q28589970 | ||
| Integrins in cancer: biological implications and therapeutic opportunities | Q29614536 | ||
| Hepatocellular carcinoma | Q29615765 | ||
| Tumor metastasis: molecular insights and evolving paradigms | Q29615908 | ||
| Circulating tumor cells, disease progression, and survival in metastatic breast cancer | Q29619276 | ||
| Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis | Q34111187 | ||
| DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrin-Rho GTPase signaling | Q34334370 | ||
| Critical role of STAT3 in melanoma metastasis through anoikis resistance | Q34334499 | ||
| Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis | Q34590225 | ||
| Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration | Q34789691 | ||
| Downregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells | Q35067883 | ||
| miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation | Q35176071 | ||
| Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms | Q35640345 | ||
| An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis | Q35654340 | ||
| miR-125b Is an adhesion-regulated microRNA that protects mesenchymal stem cells from anoikis | Q35881512 | ||
| Integrin signalling during tumour progression | Q35906078 | ||
| TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. | Q36237549 | ||
| ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells | Q36995691 | ||
| A secreted luciferase for ex vivo monitoring of in vivo processes | Q37235465 | ||
| MicroRNA control of signal transduction | Q37706077 | ||
| microRNA involvement in hepatocellular carcinoma | Q37873513 | ||
| Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities | Q37949129 | ||
| Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression | Q38237431 | ||
| Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2. | Q38259629 | ||
| Enhanced Gaussia luciferase blood assay for monitoring of in vivo biological processes | Q40619313 | ||
| Distinct FAK-Src activation events promote alpha5beta1 and alpha4beta1 integrin-stimulated neuroblastoma cell motility. | Q41342957 | ||
| MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway | Q46255425 | ||
| MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway | Q47616223 | ||
| Circulating tumour cells in non-metastatic breast cancer: a prospective study | Q47652073 | ||
| Circulating tumor cells in patients with breast cancer dormancy | Q81208525 | ||
| c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma | Q85198781 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 2277-2289 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin | |
| P478 | volume | 6 |
| Q40072469 | Anoikis resistance and oncoviruses. |
| Q38311376 | Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties |
| Q37641583 | Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs |
| Q92447657 | Dissimilar Appearances Are Deceptive-Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma |
| Q92840399 | Downregulation of serum miR-26a predicts poor clinical outcome of papillary thyroid carcinoma |
| Q28084310 | Evaluation of MicroRNAs Regulating Anoikis Pathways and Its Therapeutic Potential |
| Q91906924 | Ezrin promotes breast cancer progression by modulating AKT signals |
| Q64290681 | Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma |
| Q38736898 | Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1. |
| Q36140675 | Macrolide analog F806 suppresses esophageal squamous cell carcinoma (ESCC) by blocking β1 integrin activation |
| Q38823802 | MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development |
| Q37046835 | MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2. |
| Q38714879 | MiR-26a enhances invasive capacity by suppressing GSK3β in human lung cancer cells |
| Q35781465 | MicroRNA-200a suppresses metastatic potential of side population cells in human hepatocellular carcinoma by decreasing ZEB2 |
| Q49790324 | MicroRNA-26a and Tumor |
| Q37317285 | MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5. |
| Q91726315 | MicroRNAs in Animal Models of HCC |
| Q33779147 | Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells |
| Q89857320 | Pancreatic β cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving β cell function |
| Q47162440 | Prognostic value of integrin variants and expression in post-operative patients with HBV-related hepatocellular carcinoma |
| Q36210966 | Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma |
| Q37182974 | Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer |
| Q38796729 | The role of microRNA-26a in human cancer progression and clinical application |
| Q33815943 | miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis |
| Q37697065 | miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival |
| Q92968482 | miR-30b-5p acts as a tumor suppressor microRNA in esophageal squamous cell carcinoma |
| Q38710901 | miR-330-5p suppresses glioblastoma cell proliferation and invasiveness through targeting ITGA5. |
| Q26774789 | β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer |
Search more.